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Introduction
Single-stranded  DNA  oligonucleotides  (ODNs)  can  direct 
specific changes in the nucleotide sequence of DNA in a 
process known as gene editing. This technique has begun 
to  emerge  as  a  useful  genetic  tool  for  gene  therapy.  An 
increased understanding of the mechanism of action of gene 
editing has accelerated the progression toward application. 
Reaction parameters such as strand bias, suppression by 
certain  mismatch  repair  proteins  and  the  involvement  of 
DNA replication in producing altered bases have been heav-
ily investigated.1,2 While the focus of most workers remains, 
appropriately,  on  improving  and  stabilizing  the  frequency 
with which gene editing takes place (see ref. 3 for review), 
we have been examining DNA damage and its downstream 
consequences  associated  with  the  editing  reaction.4,5 The 
development of double-stranded DNA damage appears tied 
to the slower progression of genetically altered cells through 
S phase.4–15 The slowing of DNA replication and the creation 
of strand breaks may be related, perhaps by the collapse of 
stalled replication forks during the gene editing process, a 
phenomenon known to occur under normal growth conditions 
when replication forks are impeded.16–19
Optimization of the ODN-induced gene editing reaction has 
led to the identification of factors that significantly enhance or 
impede the achievement of high levels of correction. Proteins 
involved in recombinational repair and regulation, which are 
elevated during S phase, are largely supportive of the gene 
editing reaction.4,20 Additionally, replication has been shown to 
positively influence the gene editing reaction. Slowing of replica-
tion, and the subsequent increase of the proportion of targeted 
cells in S phase, results in elevated correction levels; whereas 
prohibiting S-phase progression abolishes correction.3,10–13 Fur-
thermore, the specific ODN has been shown to incorporate into 
the genome of corrected cells.14,15 The summation of current 
knowledge in the field thus far suggests a possible mechanism 
of ODN-integration in the context of replication. The associated 
DNA damage response seen in this context implicates replica-
tion stress as an outcome of gene editing and thus the incorpo-
ration of phosphorothioate ODNs may inhibit fork progression. 
In this article, we examine DNA damage and DNA breakage 
in greater detail with a particular emphasis on the specificity of 
the ODN and its chemical compositions as it relates to geno-
toxicity. To our surprise, we find that replication fork collapse21 
can occur in the presence of electroporated ODNs even in the 
absence of gene editing activity. These results suggest that 
DNA damage induced by all forms of ODNs is a global effect of 
gene editing. Phosphorothioate linkages on the standard work-
horse vector used to attain the highest frequencies of gene 
editing exacerbate these genotoxic effects.
Results
Gene editing in the HCT116-19 cell system
The model system employed herein is the human cell line 
HCT116 with a single copy of integrated mutant eGFP gene 
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(HCT116-19). Correction of the single-base nonsense muta-
tion by specific ODNs results in the production of fluores-
cent  eGFP  protein,  allowing  phenotypic  correction  to  be 
monitored  via  flow  cytometry.  As  shown  in  Figure  1,  the 
mutant eGFP gene contains a stop codon (TAG) in place 
of the wild-type tyrosine codon (TAC). The standard work-
horse ODNs, 72NT, 72NT-U, 72NT-PM are 72-mers that are 
complementary to the nontranscribed (G->C) strand of the 
eGFP  gene.  The  perfect-match  ODN,  72NT-PM  comple-
ments and binds to the nontranscribed strand, but does not 
create a mismatched base pair. The asterisks indicate three-
  phosphorothioate bonds on either end of the ODN. 72NT-U 
is the same length and sequence as 72NT, but does not have 
any phosphorothioate bonds (unmodified). The 72NS ODN 
has no known complementarity to the target region or the 
human genome as accessed via BLAST (NIH) and BLAT 
(UCSC) analyses.5
The  experimental  strategy  of  ODN-induced  gene  edit-
ing in this system has been previously reported and widely 
reviewed.22–24 Briefly, cells (2.5 × 106) are electroporated with 
ODN after 24 hours of synchronization with aphidicolin, a 
drug that reversibly synchronizes cells in early S phase. Syn-
chronization and release has been shown to enhance correc-
tion efficiency, most likely because it elevates the number of 
cells passing through in S phase as a population in the pres-
ence of the ODN.4,6,9,10,22,24,25 Extensive washing of the cells 
removes effective concentrations of aphidicolin, which as a 
reagent does not influence the gene editing reaction (see ref. 
4). Cells are allowed to recover after electroporation in full 
growth media for the specified time frame before analysis. 
When 72NT is electroporated into the cells at various levels, 
a dose response of gene editing is observed (Figure 2a). 
In contrast, 72NS does not support correction of the eGFP 
mutation as predicted and previously reported.5 These data 
validate the assay system used in this paper and display the 
specificity of the gene editing reaction.
Figure 2b illustrates one of the barriers to the implemen-
tation of gene editing as a therapeutic option; the progres-
sive loss of percentage of corrected cells. This phenomenon 
has been widely reported (see refs.  5,6,7,25,26 and references 
within) with reduced correction efficiencies easily observed 
at 96 hours. Here, we simply extend the time points at which 
Figure 1  Model system for gene editing in mammalian cells. The target enhanced green fluorescent protein (eGFP) sequence con-
tains a TAG stop codon in place of the wild-type TAC tyrosine codon (bold and underlined). The mutant eGFP that is produced is truncated 
and nonfluorescent. Specific DNA oligonucleotides (ODNs) were designed that can hybridize to the nontranscribed (NT) strand (72NT, 
72NT-U, 72NT-PM). 72NT-PM is a perfect-match ODN that is designed to bind the target NT strand but not elicit a base-exchange event. 
72NS is a random sequence ODN bearing no complementarity to the eGFP gene. *Phosphorothioate linkages and the bold capitalized 
letter indicates the target base.
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Figure 2  Gene editing in HCT116-19 cells. (a) HCT116-19 cells were synchronized with aphidicolin for 24 hours and then washed prior 
to the introduction of the indicated amount of DNA oligonucleotides (ODN); 72NT or 72NS. Gene editing activity was measured by the 
emergence of enhanced green fluorescent protein (eGFP) by flow cytometry analysis, 24 hours after the addition of the ODN. Correction 
efficiency (%) was determined as the percent of eGFP positive cells in the overall viable population. (b) HCT116-19 cells were synchro-
nized for 24 hours and electroporated using standard conditions with 8 µmol/l 72NT. Time points were taken at 72, 96, 120, 44, and 168 
hours respectively for analysis by FAC of eGFP (corrected cell) expression. Correction percentage was determined as the number of eGFP 
positive cells divided by the number of live cells in the population.
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evaluation for correction efficiencies were undertaken. The 
results  of  this  work  herein  may  offer  one  solution  to  this 
problem.
Recently, we observed double-strand break formation in 
response to the addition of ODNs designed to direct gene 
editing events.5 All three types of ODNs used in this study, 
72NT, 72NS, and 72NT-PM, induced chromosomal damage 
albeit to various degrees. Double-stranded DNA breakage 
can result from stress on the replication fork caused by an 
impediment  to  S-phase  progression.  Ferrara  and  Kmiec.4 
showed that the introduction of ODNs into the cell in a gene 
editing reaction activates Chk1 and Chk2 and in turn, pro-
gression through S phase is slowed. A hallmark event that 
correlates with both DNA damage and the slowing of cells 
through S phase is the phosphorylation of H2AX.17,25–27 One 
might  predict  that  H2AX  activation  will  also  be  observed 
under our standard reaction conditions. Phosphorylation of 
H2AX at serine 139 by ATM is widely accepted as a cellular 
response to DNA damage. Thus, we electroporated 72NT, 
72NT-PM, and 72NS into synchronized HCT116-19 cells and 
measured H2AX phosphorylation, 24 hours later. The results 
are displayed in Figure 3: all three ODNs induce phosphory-
lation of H2AX as judged by treatment with fluorescently con-
jugated antibodies directed against H2AX-r and visualized 
by fluorescence-activated cell sorting (FACS). As a positive 
control, hydroxyurea is used to induce this H2AX activation 
because it causes replication fork collapse. The three ODNs, 
independent  of  target  specificity,  induce  a  very  consistent 
shift in the cellular status of H2AX with activation peaks par-
titioned to the right of the profile. These data align with our 
earlier hypothesis that the amount of ODNs required to direct 
gene editing is at a level that induces a significant DNA dam-
age response in the cell.26
If the targeting reaction is associated with a slowing of 
S-phase progression,4 and this slowing is attributable to the 
ODN causing DNA breakage, vis-à-vis replication fork stress, 
we  would  predict  that  a  higher  degree  of  DNA  breakage 
would be seen during S phase. It has been previously dem-
onstrated that the proliferating cell nuclear antigen (PCNA) 
changes cellular location throughout the cell cycle.4,28,29 Dur-
ing S phase, PCNA is distinctly nuclear, while during the rest 
of the cell cycle, PCNA appears more diffuse throughout the 
cell; this relocalization can be detected with immunofluores-
cence.  It  has  been  demonstrated  that  concurrent  staining 
of γH2AX and punctate PCNA is indicative of DNA damage 
within cells positioned in S phase.30,31 In our experimental 
approach,  HCT116-19  cells  were  synchronized  in  early  S 
phase with aphidicolin, treated with ODN, and then allowed 
to recover for 20 hours before staining for PCNA (green) and 
γH2AX (red). This delay enables the dispersal of any lingering 
effects of the synchronization process. hydroxyurea, known 
to cause replication fork collapse, and thereby double-strand 
break  formation  exclusively  during  S  phase,  served  as  a 
positive control for the punctate localization of nuclear PCNA 
and γ H2AX. As can be seen in Figure 4, treatment of syn-
chronized cells with an ODN (72NT) designed to modify the 
genomic sequence results in DNA damage during S phase; 
the appearance of distinct localization of punctate PCNA and 
γH2AX positive cells. Cells treated with a nonspecific ODN 
(72NS) however also show γH2AX positive cells at a level 
comparable to 72NT; the γH2AX positive cells also appear 
to  have  punctate,  S  phase-specific  PCNA  staining.  In  the 
absence of ODN, few cells exhibit H2AX activated staining. 
Thus, target specificity is not a differential factor in the DNA 
damage response during gene editing when cells are posi-
tioned in S phase.
Figure 3  Fluorescence-activated cell sorting (FACS) analysis of the phosphorylation of H2AX. HCT116-19 cells synchronized 
with 2 µmol/l aphidicolin 24 hours before the addition of 2 mmol/l hydroxyurea (HU) or 4 µmol/l 72NT-PM, 72NT, or the 72NS DNA 
  oligonucleotides (ODN). The reaction was allowed to proceed for 24 hours after which time the cells were processed for staining with 
  antibodies directed against pH2AX. Analyses took place on a Guava EasyCyte 5HT Flow Cytometer (see Materials and Methods section) 
and phosphorylation is assessed by the egree of shift of the cell population to the right. The number in the upper right hand corner indicates 
the percentage of cells scoring positive for H2AX activation.
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Termini modification of oligonucleotides can affect the 
degree of DNA breakage during gene editing
Historically,  most  ODNs  used  for  gene  editing  have  been 
designed  with  modifications  that  prevent  nuclease  degra-
dation in the cell. These ODNs direct the highest levels of 
nucleotide exchange. As such, the ODNs used in the pre-
vious experiments contain three nonhydrolyzable phospho-
rothioate  linkages  on  both  termini.  Recently,  a  number  of 
independent labs demonstrated that unmodified ODNs sup-
port the gene editing reaction with a reduced level of cellular 
toxicity compared to ODNs containing the phosphorothioate 
modifications.32–36 Specifically, Aarts and te Riele35 showed 
that in post-delivery analyses of the unmodified ODN, low 
levels of DNA breakage are observed as judged by the neu-
tral COMET assay. These observations, coupled with our own 
new findings surrounding the collateral damage of modified 
ODNs, prompted us to examine the activity of the unmodified 
72-mer (72NT-U) in our gene editing assays.
Synchronized HCT116-19 cells were treated with increas-
ing amounts of 72NT or 72NT-U and we assessed the correc-
tion efficiencies of the two ODNs after 24 hours of recovery 
via flow cytometry. As seen in Figure 5a, the cells treated with 
unmodified ODN exhibit half as many correction events as cells 
treated with the modified, nuclease-protected ODN; data that 
are consistent with previous observations.5 Such results have 
made workers in the field a bit skeptical about using unmodi-
fied ODNs for gene editing. It is now clear however, that the 
collateral damage observed in cells targeted with phospho-
thioate oligonucleotides (PTOs) may be significant enough to 
seek alternative forms of ODNs. To this end, we evaluated 
genotoxic effects of 72NT-U on HCT116 cells as a function 
of gene editing in a similar fashion to the study conducted 
on 72NT. We had previously observed double-strand breaks 
in cells undergoing gene editing with PTO-ODNs.5 Now we 
asked if double-strand breaks are present when unmodified 
ODNs are used. We analyzed cells treated with increasing 
amounts of different ODNs by pulsed-field gel electrophore-
sis after 24 hours of reaction time. As seen in Figure 5b, 
both types produce the DNA streaking indicative of double-
strand break formation and as the level of ODN increases, a 
dose response is observed in both cases. However, clearly a 
lower level of breakage is seen in the samples of cells treated 
with the unmodified ODN, 72NT-U. This result aligns with the 
notion that 72NT-U has a lower genotoxic effect on cells tar-
geted for gene editing. To examine the collateral damage in 
cells treated with 72NT-U more fully, the levels of H2AX acti-
vation, via phosphorylation, in response to the introduction of 
72NT and 72NT-U, respectively were visualized. A more tepid 
response to 72NT-U than to 72NT is observed (Figures 5c 
and d). Data reveal that 20–25% less of the cell population 
score positive for H2AX-γ as judged by fluorescent antibody 
binding  and  FACS-analyses.  Thus,  one  important  marker 
for the DNA damage response, H2AX-r, is present in fewer 
cells when 72NT-U is used for gene editing. In addition, the 
degree of damage response is less when 72NT-U is used as 
opposed to 72NT. These data might suggest that not only do 
more cells possess activated H2AX, many of them achieve a 
larger extent of damage when 72NT is used.
Replication fork progression is inhibited significantly by 
the presence of 72NT in the cell, but less so by 72NT-U
Based on the data presented above, one would predict that 
an enhanced level of DNA damage response and replica-
tion stress induced by 72NT might account, in part, for the 
observed genotoxicity in targeted cells. This outcome might 
arise from the cessation of movement or stalling of replica-
tion forks as a function of the presence of 72NT. To mea-
sure the status of replication fork activity, we analyzed BrdU 
incorporation in treated cells by flow cytometry. Synchronized 
cells were released for 4 hours, at which time an ODN, 72NT, 
or 72NT-U, was delivered into the cells by electroporation; 
BrdU incorporation was then measured at 24, 48, and 72 
hours, respectively. This assay provides a view of the num-
ber of actively replicating forks; it is not a measure of the 
number of cells in S phase per se. Here, we used a FlowCol-
lect Biovariate Cell Cycle kit (Millipore, Temecula, CA) which 
identifies cells bearing actively replicating forks. The results 
are presented in Figure 6. In the untreated control panel, 
we observed a standard cell distribution with each phase of 
the cycle represented and S phase quantitated at ~12%. The 
addition of 72NT causes, over the time course of the experi-
ment, a virtual loss of any cells bearing actively replicating 
Figure 4  Colocalization of PCNA and H2AX-r during gene editing. Confocal image of HCT116-19 cells synchronized with 2 µmol/l 
aphidicolin 24 hours beforeo the addition of 2 mmol/l Hydroxyurea, 72NT or 72NS, all at 8 µmol/l final concentration. After recovery, cells 
were stained for γ H2AX (red) and PCNA (green diffuse and punctate) to identify activated cells and viewed under confocal microscopy at 
20× magnification.
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Figure 5  Correction efficiency and DNA damage effects of the integrated enhanced green fluorescent protein (eGFP) gene as 
analyzed by flow cytometry and pulsed-field gel electrophoresis (PFGE). (a) HCT116-19 cells were synchronized with 2 µmol/l aphidi-
colin for 24 hours prior to electroporation with 2, 4, or 8 µmol/l of 72NT or 72NT-unm. After a 24-hour recovery period, cells were analyzed 
via flow cytometry analysis with propidium iodide being used to determine cell viability levels. Correction efficiency (CE) was determined 
as the percent of GFP positive cells out of the live cell population. *P < 0.05. (b) PFGE analysis of HCT116-19 cells treated with 2, 4, or 
8 µmol/l 72NT or 72NT-unm for 24 hours. CPT (300 nmol/l for 24 hours) treatment is used as a positive control. The top and bottom of the 
gel are indicated as is the position of the loaded well. (c). Fluorescence-activated cell sorting (FACS) analyses of H2AX phosphorylation 
with samples of HCT116 cells treated with 30 nmol/l (CPT) or not treated (NT) or electroporated without DNA oligonucleotides (ODN). 
Electroporation only, also serves as a negative control. (D). All cell samples were treated with 8 µmol/l 72NT or 8 µmol/l 72NT-U, respec-
tively. Cells were recovered for 16 hours or 24 hours in a 48-well plate. Cells were harvested by trypsinization, fixed, permeabilized, and 
stained with pH2AX, antibodies respectively and DNA damage analysis carried out by FACS. Phosphorylation was measured by the shift, 
to the right, in the histograms. The number in the upper right hand corner of each panel indicates the percentage of cells scoring positive 
for activation or staining with the H2AX-r antibody.
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DNA forks. At 48 hours, the cells are piling up in G1 and by 
72 hours, the total viable cell number has actually diminished 
dramatically;  large  percentages  are  nonviable  at  this  time 
point. In contrast, cells treated with 72NT-U display a more 
modest reduction in the number of actively replicating DNA 
forks. There is clearly a detrimental effect with both ODNs, 
but cells treated with 72NT-U appear to induce a slower pro-
gression into G2/M but a significant number of cells remain 
active  for  replication. Thus,  it  appears  that  72NT  impacts 
active replication fork activity more dramatically than 72NT-U, 
perhaps by inducing replication fork collapse and ultimately 
double-stranded DNA breakage (see Figure 5b).
Discussion
We and others have demonstrated that single- and double-
stranded DNA breaks appear as a function of ODN-directed 
gene editing, raising concern about secondary effects and 
collateral damage in the genome.5,6 We demonstrate here 
that  transient  double-stranded  DNA  breaks  appear  during 
the gene editing reaction; breakage is seen to arise indepen-
dent of the homology to the target site. These data suggest 
that, in general, ODNs activate the DNA damage response 
pathway and inhibit the progression of cells through S phase. 
Chromosomal  breakage  occurs  on  a  global  level,  but  the 
extent of cellular disruption appears to be related to chemical 
modifications.
Previous data suggest that certain proteins, important in the 
gene editing reaction, are activated during S phase.6,8,10 Cor-
rection efficiencies are higher in replicating cells than in cells 
not allowed to progress through S phase.10–13,25,34 Proteins 
involved in homologous recombinational repair regulate the 
overall reaction with regard to the degree of correction.4,32,37 
In contrast, proteins involved in nonhomologous end joining, 
appear to have little direct effect on the correction mecha-
nism.20 These data, along with evidence of ODN integration 
into the genome,14,15 suggest a mechanism wherein the ODN 
aligns in homologous register with its target sequence during 
replication. Once incorporated, the mismatch repair system 
addresses the mismatched base pair through recognition by 
Figure 6  BrdU uptake in cells treated with 72NT or 72NT-U. Synchronized cells were released for 4 hours prior to the electroporation of 
72NT or 72NT-U. The cells were allowed to recover for the indicated times prior to being treated with BrdU for 60 minutes. Cells undergoing 
active replication were identified with the FlowCellect Bivariate Cell Cycle Kit for DNA Replication (Millipore). This kit employs a conjugated 
Anti-BrdU Alex-Flour 488 antibody mixed with propidium iodide (see Materials and Methods section). The cells were then analyzed on a 
Guava EasyCyte 5HT Flow Cytometer. The population of cells in each phase of the cell cycle is demarcated and the percentage of each 
population is presented at the right of each graph. NT; is the control of cells not treated with DNA oligonucleotides (ODN).
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MSH2/MSH6/MLH1 etc. This complex signals the nuclease 
ExoI to remove a short stretch surrounding the mismatched 
base pair.38 A modified ODN would be resistant to removal by 
ExoI, thereby causing fork movement to be slowed or stopped. 
Under these circumstances, fork collapse can occur and a 
double-stranded DNA break can then ensue. Our previous 
data,5 suggest that some of these breaks are repaired and 
the modified ODN incorporates into the double helix resulting 
in a new nucleotide in the genome. In the specific reaction, 
the degree of breakage seems to be related to the amount 
of 72NT that is designed to anneal to the target site. Dilution 
experiments5 show that ds breaks correlate to the level of 
specific ODN present in a gene editing reaction. This idea 
must be understood within the context of the HCT116 cell line 
used in this study. These cells lack some of the MMR proteins 
that form the complex initializing ExoI entry. Since PCNA and 
RFC are present, there may be enough degeneracy in the 
signals so that once the PTO-ODN aligns in homologous reg-
ister, ExoI may be present to some degree to initialize nucle-
ase activity. But again, HCT116 cells lack MLH1 and thus 
the attraction of ExoI to the target site could be problematic. 
Alternatively, other nuclease activities associated with poly-
merase editing functions could be involved directly with the 
PTO-ODN. Considering, however, that gene editing has been 
shown to be more active on the lagging strand of a replication 
fork,39 it is not unlikely that nuclease activity associated with 
the processing of Okazaki fragments cold be involved in the 
reaction. Taken together, we now suggest that DNA damage 
and double-strand DNA breakage can develop as a function 
of the ODN interacting with and inhibiting the progression of 
the replication machinery.
We  have  used  modified  ODNs  (phosphorothioate) 
because they are resistant to nuclease activity and typically 
provide  higher  correction  levels  as  compared  to  unmodi-
fied ODNs.15,35,36 Pulsed-field gel electrophoresis analyses 
herein revealed that double-strand break formation is pres-
ent in cells treated with either modified or unmodified ODN, 
but the unmodified ODN induces less breakage. This differ-
ence in DNA breakage levels can be attributed to the deg-
radation of the unmodified ODN. If we once again refer to 
the Aarts and te Riele model38 described above, one can 
imagine that an unmodified ODN incorporated near or at a 
replication fork would be, in most cases, efficiently removed 
by nuclease activity from some molecular process going on 
in the region. Thus, fewer forks stall and only a small amount 
of double-stranded DNA breakage would then be generated. 
This removal would also account for the lower number of 
successful gene editing events when unmodified ODNs are 
used. Modified ODNs may resist removal by long enough to 
direct the nucleotide exchange but can concurrently cause 
double-strand breakage by inducing fork collapse.
Our observations of gene editing-induced DNA damage 
lead us to believe that replication fork collapse is the most 
likely cause of DNA breakage, and perhaps the overall DNA 
damage response. By several benchmarks used in our sys-
tem, DNA damage response and localization of PCNA occur 
at  roughly  the  same  level  as  seen  when  either  72NT  or 
72NT-PM is used as the targeting ODN. This is likely due to 
the overwhelming number of DNA free ends that enter the 
nucleus when the ODN is delivered by electroporation. Free 
ends ignite a DNA damage response which may, by itself, 
cause a stalling of replication forks and a wide-spread slow-
down  in  S-phase  progression.  Fork  collapse  and  double-
strand breakage is likely under these circumstances even 
without  gene  editing  activity  because  some  forks  simply 
don’t recover after the DNA damage response pathway is 
activated.
Thus,  we  believe  that  two  distinct  pathways  account 
for  DNA  damage  and  double-strand  breakage  observed 
as a function of gene editing. As reported previously (and 
extended herein),5 specific or nonspecific ODN can induce a 
DNA damage response with the activation of H2AX, etc. But, 
the specific ODN (here 72NT) appears to induce DSBs at a 
level that is higher than its nonspecific counterpart. In this 
paper, we suggest two origins for the evolution of DSBs. The 
first is a relatively succinct and elegant fork collapse induced 
by the homologous alignment of the ODN to the target site. 
Inhibition of normal MMR activity by the modified ODN leads 
ultimately to the stalling of fork movement followed by devel-
opment of double- strand breaks. This view is supported by a 
recent RNAi screen by Aarts and te Riele.40 Using an RNAi 
approach,  they  conducted  a  screening  of  proteins  impli-
cated in the ODN-induced gene editing reaction on a mouse 
embryonic stem cell system. Interestingly, knockdown of TLS 
proteins, involved in overcoming replication stress, resulted 
in a considerable depreciation of gene editing. The second 
pathway is more global in nature, based on a mass-action 
effect of large levels of ODNs, which overwhelms the cell. The 
presence of so many DNA free ends induces a protective 
response in a somewhat artifactual way that can also lead 
indirectly to DSB. Hence, there may be a specific mechanism 
of double-strand breakage buried under a global nonspecific 
reaction, which by itself can lead to collateral damage.
Clearly, replication activity is least affected when unmodified 
ODNs are used for gene editing, although there is some neg-
ative impact. Induction of the DNA damage response pathway 
and double-strand breaks do occur, but appear to be more 
moderate. Unmodified ODNs, however, direct <50% of the 
amount of gene editing seen with modified ODNs, again due 
in all likelihood to their efficient removal from the target site 
after alignment and incorporation. Thus, it may come down to 
a choice between efficiency of correction and the induction of 
collateral damage, a cost benefit analysis for consideration as 
gene editing moves closer to therapeutic application.
Materials and Methods
Cell line and culture conditions. HCT116 cells were acquired 
from American Type Cell Culture (Manassas, VA). The inte-
grated  HCT116  clone  19  (HCT116-19)  was  created  by 
integrating a pEGFP-N3 vector (Clontech, Palo Alto, CA) con-
taining a mutated enhanced green fluorescent protein (eGFP) 
gene, as described by Hu et al.21 The mutated eGFP gene 
has a nonsense mutation at position +67 resulting in non-
functional eGFP protein. For these experiments, HCT116-19 
cells were cultured in McCoy’s 5A Modified medium (Sigma-
Aldrich, St Louis, MO) supplemented with 10% fetal bovine 
serum, 2 mmol/l l-glutamine, and 1% penicillin/streptomycin. 
Cells were maintained at 37 °C and 5% CO2.Molecular Therapy–Nucleic Acids
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Oligonucleotide  designs  and  eGFP  targeting.  ODNs  were 
synthesized  by  Integrated  DNA  Technologies  (Coralville, 
IA). The correcting oligonucleotide is a 72-mer that comple-
ments the nontranscribed strand of the target mutant eGFP 
gene.  It  has  a  centrally  positioned  mismatch  that  directs 
conversion of the mutant stop codon to the wild-type eGFP 
tyrosine, thereby allowing expression of functional eGFP. A 
perfect-match ODN was also designed as a 72-mer to target 
the nontranscribed strand, but would not induce a correction 
event. A nonspecific ODN bears a DNA sequence that has 
no homology to the target gene. Each ODN, unless otherwise 
noted, has three-phosphorothioate linkages on either end to 
help prevent nuclease degradation: 72NT-U does not have 
any phosphorothioate linkages.
Before eGFP targeting, cells were treated with aphidicolin 
for 24 hours in complete growth medium (unless otherwise 
noted). Cells were then trypsinized and harvested by centrif-
ugation. Cells were resuspended to a concentration of 2.5 × 
107 cells/ml in serum-free medium and 100 µl transferred to a 
4-mm gap cuvette (BioExpress, Kaysville, UT). The respective 
ODN was added to a final concentration of 8 µmol/l (unless 
otherwise noted) and the cells were electroporated (250 V, 13 
ms, 2 pulses, 1-second interval) using a BTX Electro Square 
Porator ECM 830 (BTX Instrument Division, Holliston, MA). 
The electroporated cells were then transferred to a 100-mm 
dish and allowed to recover in complete growth medium for 
24 hours (unless otherwise noted) at 37 °C.
Flow  cytometry.  EGFP  fluorescence  was  measured  by  a 
BD FACSAria II flow cytometer with FACSDiva (BD Biosci-
ences,  San  Jose,  CA)  24  hours  after  electroporation  with 
ODN. Cells were harvested by trypsinization, washed once 
with phosphate-buffered saline (PBS), and resuspended in 
buffer (0.5% bovine serum albumin, 2 mmol/l EDTA, 2 µg/
ml propidium iodide in PBS). Correction efficiency was then 
calculated as the percentage of eGFP positive cells out of the 
live cell population.
Fluorescence of eGFP was also measured by FACS analy-
sis using a Guava EasyCyte 5HT Flow Cytometer (Millipore). 
Cells were harvested by trypsinization, washed once with 
1× PBS−/− and resuspended in buffer (0.5% bovine serum 
albumin, 2 mmol/l EDTA, 2 µg/ml propidium iodide in PBS−/−). 
eGFP fluorescence was calculated two ways: the percent-
age of the total live eGFP positive population over the total 
live population and the percentage of the total eGFP positive 
population (live + dead) over the total cell population. Error 
bars are produced from three sets of data points generated 
over three separate experiments.
Analysis of DNA damage activity. HCT116-19 cells were syn-
chronized with 6 µmol/l aphidicolin for 24 hours, released for 
4 hours and targeted with ODN (with electroporation) allowed 
to recover in a 48-well plate in complete growth media for spe-
cific amount of time. Cells were then treated with the FlowCel-
lect DNA Damage Kit (Millipore) specific for phosphorylated 
Histone H2AX. It uses a fluorescently labeled antibody opti-
mized for analysis using flow cytometry. Briefly, 1 × 106 cells 
were harvested by trypsinization, washed with 1× wash buffer, 
fixed for 20 minutes on ice, washed again with wash buffer, and 
permeabilized for 20 minutes on ice. After permeabilization, 
200,000 cells were transferred to a V-bottom 96-well plate, 
washed with assay buffer and then resuspended in 85 µl of 
assay buffer. The antibody (pH2AX) was added (5 µl) to the 
cells and allowed to incubate for one hour at room tempera-
ture. After incubation, the cells were washed with assay buffer 
and then resuspended in 200 µl of assay buffer and analyzed 
on a Guava EasyCyte 5HT Flow Cytometer (Millipore). The 
position along the x-axis correlates to the amount of phos-
phorylated H2AX, with a shift further to the right signifying a 
positive signal—phosphorylated H2AX. The percentage (out 
of total population) of phosphorylated H2AX is determined by 
the gating imposed by the positive and negative controls (non-
transcribed and CPT, respectively). Anything under the right 
gate (R5) is considered to be positive and everything to the left 
is considered to be negative, according to the manufacturer.
Immunofluorescence. Electroporated cells were immediately 
plated in 8-well chambers (100,000 cells/well) and allowed to 
recover for 20 hours. Control cells were treated with 2 mmol/l 
hydroxyurea, which is known to cause replicated fork collapse 
and double-strand breaks exclusively in S phase for 20 hours. 
γH2AX and PCNA: Cells were then washed for 5 minutes at 
37 °C in PBS. Cells were fixed in 4% paraformaldehyde for 
30  minutes  at  room  temperature.  After  washing  with  PBS, 
cells were permeabilized with 0.5% Triton X-100 in PBS for 
10 minutes at room temperature. Cells were incubated in 10% 
normal goat serum for 10 minutes and then for 30 minutes 
in a 10% milk solution. γH2AX and PCNA antibodies were 
added at a dilution of 1:100 in 10% milk and kept at 4 °C 
overnight (γH2AX: Cell Signaling, Boston, MA; PCNA: Santa 
Cruz Biotechnology, Santa Cruz, CA). The next day, cells were 
washed four times for 10 minutes each in 0.1% Triton X-100. 
The secondary antibodies were then added for 1 hour at room 
temperature  (γ H2AX:  α-rabbit,  goat-Cy3;  PCNA:  α-mouse, 
goat-Alexa Fluor 488). Cells were again washed four times for 
10 minutes each in 0.1% Triton X-100. Cells were visualized 
with a BioRad/Zeiss MRC 1,024 on an inverted Nikon Diaphot 
300 (Nikon, Tokyo, Japan).
Pulsed-field gel electrophoresis. Targeted cells were allowed 
to recover for specified times in 60 mm dishes. Cells were 
harvested by trypsinization and 1 × 106 cells were isolated 
and pelleted by centrifuging at 1,500 r.p.m. for 5 minutes. 
Cells  were  washed  once  in  PBS  and  resuspended  in  50 
mmol/l EDTA. Cells were combined in a 1:1 ratio with 1% low 
melt agarose (GIBCO; Invitrogen, Carlsbad, CA) in 50 mmol/l 
EDTA and transferred to plug molds. Plugs were allowed to 
cool at 4 °C for ~30 minutes before being transferred to lysis 
solution (50 mmol/l EDTA, 1% N-laurosylsarcosine, 1 mg/ml 
proteinase K). Cells were kept in lysis solution at 50 °C for 24 
hours while shaking. Plugs were then washed four times in 
1× TE buffer before being inserted into a 1% pulsed field cer-
tified agarose gel (Bio-Rad, Hercules, CA). The gel was run 
for 24 hours using a 120° field angle, 60–240 s switch time, 
4 V/cm at 14 °C. The next day the gel was stained for 1 hour 
in ethidium bromide prior to imaging on an Alpha Innotech 
Fluorchem Q (Cell Biosciences, Santa Clara, CA).
Measurement  of  BrdU  incorporation  by  flow  cytometry. 
HCT116 cells were synchronized with 6 µmol/l aphidicolin www.moleculartherapy.org/mtna
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for 24 hours, released for 4 hours and targeted with 6 µmol/l 
72NT, 72NT-U by electroporation and allowed to recover in 
a 6-well plate in complete growth media for specific amount 
of time. Cells were then treated with the FlowCellect Bivari-
ate Cell Cycle Kit for DNA Replication Analysis Kit (Millipore). 
This kit identifies cells undergoing replication in S phase of the 
cell cycle by employing a directly conjugated Anti-BrdU Alexa 
Fluor  488  antibody  plus  propidium  iodide,  a  DNA-  binding 
dye. This combination allows for the bivariate detection in two 
dimensions without the need for software modules and, there-
fore, can follow labeled cells through the cell cycle. Briefly, 
after recovery, cells were labeled with 1× BrdU for 60 minutes 
and then harvested by trypsinization followed by centrifuga-
tion, washed with 1× wash buffer, and fixed for 20 minutes 
on ice. After fixation, 250,000 cells were washed again with 
wash buffer, transferred to a V-bottom 96-well plate, and per-
meabilized for 20 minutes on ice. The cells were washed with 
assay buffer and then DNase I was added at a concentration 
of 300 µg/ml and incubated for one hour at 37 °C. The DNA 
denaturation reagent was removed by centrifugation and then 
washed with assay buffer. The cells are then resuspended in 
95 µl assay buffer and 5 µl of the anti-BrdU Alexa Fluor 488 
antibody was added and incubated on ice for 1 hour. After the 
incubation, the cells were washed with assay buffer and the 
DNA was stained with a freshly prepared solution of propid-
ium iodide/RNase and allowed to incubate for 30 minutes at 
room temperature. The cells were then analyzed on a Guava 
EasyCyte 5HT Flow Cytometer (Millipore).
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